Lannett Co Inc (LCI) 41.15 $LCI
Valeant (VRX) in Focus on Intensifying Government Probe
Zacks Equity Research - Zacks Investment Research - Fri Oct 16, 1:20PM CDT
Valeant (VRX) has hit a rough patch ever since concerns arose about the irrational increase in drug prices by U.S. pharma/biotech companies.
LCI: 41.15 (-2.50), VRX: 118.61 (-28.13), ANAC: 93.73 (+1.31)
Prothena to Start Phase IIb Study on AL Amyloidosis Drug
Zacks Equity Research - Zacks Investment Research - Fri Oct 16, 1:10PM CDT
Prothena (PRTA) announced that it will commence a phase IIb study on NEOD001 for patients suffering from AL amyloidosis and persistent cardiac dysfunction.
LCI: 41.15 (-2.50), ANAC: 93.73 (+1.31), PRTA: 47.23 (+0.39)
How Valeant is changing the Pharmaceutical Industry?
Zacks Equity Research - Zacks Investment Research - Thu Oct 15, 3:50PM CDT
It is still early to say if Valeant's (VRX) strategic plan will affect the general behavior of companies operating in the pharmaceutical sector.
IPXL: 35.01 (-0.59), LCI: 41.15 (-2.50), ENDP: 54.46 (-8.37), VRX: 118.61 (-28.13)
Lannett passes US FDA approval for Memantine Hydrochloride Oral Solution, 2 mg/ml to treat dementia associated with Alzheimer's disease
M2 - Thu Oct 15, 3:06AM CDT
Pharmaceutical products business Lannett Company (NYSE:LCI) revealed on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Memantine Hydrochloride Oral Solution 2 mg/ml.
LCI: 41.15 (-2.50)
Shire's Cinryze Gets Fast Track Status for Additional Indication
Zacks Equity Research - Zacks Investment Research - Wed Oct 14, 2:45PM CDT
Shire announced that its HAE drug Cinryze has been granted Fast Track designation for antibody mediated rejection (AMR) in renal transplant recipients by the FDA.
LCI: 41.15 (-2.50), SHPG: 206.67 (-2.87), AZN: 30.47 (-0.46)
Lannett Receives FDA Approval For Memantine Hydrochloride Oral Solution, 2 mg/mL
PR Newswire - Wed Oct 14, 5:53AM CDT
Lannett Company, Inc. (NYSE: LCI) today announced that its wholly owned subsidiary, Silarx Pharmaceuticals, Inc., has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Memantine Hydrochloride Oral Solution 2 mg/mL, the therapeutic equivalent to the reference listed drug Namenda® Oral Solution, 2 mg/mL of Forest Pharmaceuticals. According to IMS, for the year ended June 2015 total sales of Memantine Hydrochloride Oral Solution 2 mg/mL at Average Wholesale Price (AWP) were approximately $12 million.
LCI: 41.15 (-2.50)
Zacks Investment Ideas feature highlights: American Woodmark, Footlocker, Lannett, Ryanair Holdings and Carrols
Zacks Equity Research - Zacks Investment Research - Tue Oct 13, 8:30AM CDT
Zacks Investment Ideas feature highlights: American Woodmark, Footlocker, Lannett, Ryanair Holdings and Carrols
LCI: 41.15 (-2.50), RYAAY: 79.43 (-0.75), FL: 70.18 (+0.42), TAST: 12.34 (-0.25), AMWD: 68.99 (-0.55)
Zafgen (ZFGN) in Focus: Stock Plunges 35.6%
Zacks Equity Research - Zacks Investment Research - Tue Oct 13, 7:32AM CDT
Zafgen (ZFGN) fell nearly 36% in the last trading session amid huge volumes, continuing its recent trend, as the stock is now down over 44% in the past one month.
ZFGN: 10.72 (-0.52), LCI: 41.15 (-2.50)
5 Best Under the Radar Stocks
Tracey Ryniec - ZACKS - Mon Oct 12, 1:02PM CDT
5 Best Under the Radar Stocks
LCI: 41.15 (-2.50), RYAAY: 79.43 (-0.75), FL: 70.18 (+0.42), AMWD: 68.99 (-0.55), TAST: 12.34 (-0.25)
The Zacks Analyst Blog Highlights: Delta Air Lines, Tyson Foods, United Continental Holdings, Ally Financial and Lannett Company
Zacks Equity Research - Zacks Investment Research - Fri Oct 09, 8:30AM CDT
The Zacks Analyst Blog Highlights: Delta Air Lines, Tyson Foods, United Continental Holdings, Ally Financial and Lannett Company
LCI: 41.15 (-2.50), ALLY: 20.21 (-0.09), DAL: 49.44 (-0.71), TSN: 46.23 (+0.14), UAL: 54.55 (-1.20)
5 Value Stocks That Brokers Love
Zacks Equity Research - Zacks Investment Research - Thu Oct 08, 8:40AM CDT
Only a fundamentally strong company has the calibre to achieve its growth potential despite an unsupportive economic background. One such foolproof approach is investing in undervalued stocks that more than 80% brokers recommend.
LCI: 41.15 (-2.50), ALLY: 20.21 (-0.09), DAL: 49.44 (-0.71), TSN: 46.23 (+0.14), UAL: 54.55 (-1.20)
Why Valeant's (VRX) Shares Plummeted in Monday Trading
Zacks Equity Research - Zacks Investment Research - Tue Sep 29, 3:41PM CDT
Valeant (VRX) is one of the hardest hit stocks following Hillary Clinton's tweet on "price gouging." The company saw its shares plummet 16.5% yesterday.
ACRX: 3.31 (-0.12), LCI: 41.15 (-2.50), VRX: 118.61 (-28.13), CORT: 3.66 (+0.06)
Jazz Pharmaceuticals (JAZZ) Crumbles: Stock Falls by 7.7%
Zacks Equity Research - Zacks Investment Research - Tue Sep 29, 7:42AM CDT
Jazz Pharmaceuticals saw a big move last session, as the company's shares fell nearly 8% on the last trading day
LCI: 41.15 (-2.50), JAZZ: 121.94 (-4.06)
Pacira Pharmaceuticals (PCRX) Crumbles: Stock Falls by 7.7%
Zacks Equity Research - Zacks Investment Research - Thu Sep 24, 7:34AM CDT
Pacira Pharmaceuticals (PCRX) fell nearly 8% in the last trading session amid huge volumes, continuing its recent trend, as the stock is down nearly 18% since Sep 17.
LCI: 41.15 (-2.50), PCRX: 39.43 (-1.88)
Oil, Metals Prices Hurt Stocks; Car Makers, Miners, Biotechs Sacked
at Investor's Business Daily - Tue Sep 22, 9:46AM CDT
Sellers owned the early show on Tuesday, with stocks opening to losses that were broad and deep. The Nasdaq quickly slumped 1.5%. The Dow Jones industrial average and the S&P 500 each dropped 1.3%. Volume was tightly mixed, up 8% on the NYSE and 3%...
SPLS: 12.58 (+0.09), VRX: 118.61 (-28.13), F: 15.41 (+0.03), UTX: 97.97 (+2.35), FCAU: 15.20 (-0.74), NTAP: 33.40 (-0.32), TTM: 28.78 (-0.12), KMX: 57.30 (+0.35), LCI: 41.15 (-2.50), AZO: 745.29 (-0.65), GM: 35.42 (+1.94), MCD: 102.54 (-1.30)
McKesson to Buy UDG Healthcare's Pharmaceutical Business
Zacks Equity Research - Zacks Investment Research - Mon Sep 21, 2:55PM CDT
McKesson Corporation (MCK) signed an agreement to purchase UDG Healthcare's pharmaceutical distribution division for 408 million euro in cash.
LCI: 41.15 (-2.50), MCK: 186.62 (-2.71), ADHD: 6.49 (-0.20)
Major Indexes Still Mixed; Red Hat Up Ahead Of Earnings
at Investor's Business Daily - Mon Sep 21, 1:52PM CDT
Stocks have come off their session lows, but were still mixed late Monday. The Nasdaq cut a 0.6% deficit to 0.2%. But the tech-laden index was up as much as 1.1% intraday. The S&P 500 edged up 0.2% while the Dow Jones industrial average outperformed...
AGN: 259.00 (-4.42), LCI: 41.15 (-2.50), VRX: 118.61 (-28.13), CYBR: 46.41 (-3.11), RHT: 76.81 (-1.45), ILMN: 140.17 (-4.93), REGN: 518.53 (+3.86)
3 Reasons Why Lannett Company (LCI) is a Great Value Stock
Zacks Equity Research - Zacks Investment Research - Fri Sep 18, 7:52AM CDT
Lannett Company is a solid value stock that is very well-positioned for gains in the near term
LCI: 41.15 (-2.50)
'Mad Money' Lightning Round: Buy, Buy, Buy Amazing Starbucks
at The Street - Thu Sep 17, 5:00AM CDT
Cramer prefers Wells Fargo over HSBC Holdings and Kroger over Whole Foods Markets.
WFM: 32.98 (-0.24), SBUX: 60.53 (-0.35), LCI: 41.15 (-2.50), KR: 38.08 (+0.36), HSBC: 38.93 (-0.94), WFC: 53.12 (+0.04)
Valeant (VRX) in Focus on Intensifying Government Probe
Zacks Equity Research - Zacks Investment Research - Fri Oct 16, 1:20PM CDT
Valeant (VRX) has hit a rough patch ever since concerns arose about the irrational increase in drug prices by U.S. pharma/biotech companies.
LCI: 41.15 (-2.50), VRX: 118.61 (-28.13), ANAC: 93.73 (+1.31)
Prothena to Start Phase IIb Study on AL Amyloidosis Drug
Zacks Equity Research - Zacks Investment Research - Fri Oct 16, 1:10PM CDT
Prothena (PRTA) announced that it will commence a phase IIb study on NEOD001 for patients suffering from AL amyloidosis and persistent cardiac dysfunction.
LCI: 41.15 (-2.50), ANAC: 93.73 (+1.31), PRTA: 47.23 (+0.39)
How Valeant is changing the Pharmaceutical Industry?
Zacks Equity Research - Zacks Investment Research - Thu Oct 15, 3:50PM CDT
It is still early to say if Valeant's (VRX) strategic plan will affect the general behavior of companies operating in the pharmaceutical sector.
IPXL: 35.01 (-0.59), LCI: 41.15 (-2.50), ENDP: 54.46 (-8.37), VRX: 118.61 (-28.13)
Lannett passes US FDA approval for Memantine Hydrochloride Oral Solution, 2 mg/ml to treat dementia associated with Alzheimer's disease
M2 - Thu Oct 15, 3:06AM CDT
Pharmaceutical products business Lannett Company (NYSE:LCI) revealed on Wednesday the receipt of approval from the US Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Memantine Hydrochloride Oral Solution 2 mg/ml.
LCI: 41.15 (-2.50)
Shire's Cinryze Gets Fast Track Status for Additional Indication
Zacks Equity Research - Zacks Investment Research - Wed Oct 14, 2:45PM CDT
Shire announced that its HAE drug Cinryze has been granted Fast Track designation for antibody mediated rejection (AMR) in renal transplant recipients by the FDA.
LCI: 41.15 (-2.50), SHPG: 206.67 (-2.87), AZN: 30.47 (-0.46)
Lannett Receives FDA Approval For Memantine Hydrochloride Oral Solution, 2 mg/mL
PR Newswire - Wed Oct 14, 5:53AM CDT
Lannett Company, Inc. (NYSE: LCI) today announced that its wholly owned subsidiary, Silarx Pharmaceuticals, Inc., has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Memantine Hydrochloride Oral Solution 2 mg/mL, the therapeutic equivalent to the reference listed drug Namenda® Oral Solution, 2 mg/mL of Forest Pharmaceuticals. According to IMS, for the year ended June 2015 total sales of Memantine Hydrochloride Oral Solution 2 mg/mL at Average Wholesale Price (AWP) were approximately $12 million.
LCI: 41.15 (-2.50)
Zacks Investment Ideas feature highlights: American Woodmark, Footlocker, Lannett, Ryanair Holdings and Carrols
Zacks Equity Research - Zacks Investment Research - Tue Oct 13, 8:30AM CDT
Zacks Investment Ideas feature highlights: American Woodmark, Footlocker, Lannett, Ryanair Holdings and Carrols
LCI: 41.15 (-2.50), RYAAY: 79.43 (-0.75), FL: 70.18 (+0.42), TAST: 12.34 (-0.25), AMWD: 68.99 (-0.55)
Zafgen (ZFGN) in Focus: Stock Plunges 35.6%
Zacks Equity Research - Zacks Investment Research - Tue Oct 13, 7:32AM CDT
Zafgen (ZFGN) fell nearly 36% in the last trading session amid huge volumes, continuing its recent trend, as the stock is now down over 44% in the past one month.
ZFGN: 10.72 (-0.52), LCI: 41.15 (-2.50)
5 Best Under the Radar Stocks
Tracey Ryniec - ZACKS - Mon Oct 12, 1:02PM CDT
5 Best Under the Radar Stocks
LCI: 41.15 (-2.50), RYAAY: 79.43 (-0.75), FL: 70.18 (+0.42), AMWD: 68.99 (-0.55), TAST: 12.34 (-0.25)
The Zacks Analyst Blog Highlights: Delta Air Lines, Tyson Foods, United Continental Holdings, Ally Financial and Lannett Company
Zacks Equity Research - Zacks Investment Research - Fri Oct 09, 8:30AM CDT
The Zacks Analyst Blog Highlights: Delta Air Lines, Tyson Foods, United Continental Holdings, Ally Financial and Lannett Company
LCI: 41.15 (-2.50), ALLY: 20.21 (-0.09), DAL: 49.44 (-0.71), TSN: 46.23 (+0.14), UAL: 54.55 (-1.20)
5 Value Stocks That Brokers Love
Zacks Equity Research - Zacks Investment Research - Thu Oct 08, 8:40AM CDT
Only a fundamentally strong company has the calibre to achieve its growth potential despite an unsupportive economic background. One such foolproof approach is investing in undervalued stocks that more than 80% brokers recommend.
LCI: 41.15 (-2.50), ALLY: 20.21 (-0.09), DAL: 49.44 (-0.71), TSN: 46.23 (+0.14), UAL: 54.55 (-1.20)
Why Valeant's (VRX) Shares Plummeted in Monday Trading
Zacks Equity Research - Zacks Investment Research - Tue Sep 29, 3:41PM CDT
Valeant (VRX) is one of the hardest hit stocks following Hillary Clinton's tweet on "price gouging." The company saw its shares plummet 16.5% yesterday.
ACRX: 3.31 (-0.12), LCI: 41.15 (-2.50), VRX: 118.61 (-28.13), CORT: 3.66 (+0.06)
Jazz Pharmaceuticals (JAZZ) Crumbles: Stock Falls by 7.7%
Zacks Equity Research - Zacks Investment Research - Tue Sep 29, 7:42AM CDT
Jazz Pharmaceuticals saw a big move last session, as the company's shares fell nearly 8% on the last trading day
LCI: 41.15 (-2.50), JAZZ: 121.94 (-4.06)
Pacira Pharmaceuticals (PCRX) Crumbles: Stock Falls by 7.7%
Zacks Equity Research - Zacks Investment Research - Thu Sep 24, 7:34AM CDT
Pacira Pharmaceuticals (PCRX) fell nearly 8% in the last trading session amid huge volumes, continuing its recent trend, as the stock is down nearly 18% since Sep 17.
LCI: 41.15 (-2.50), PCRX: 39.43 (-1.88)
Oil, Metals Prices Hurt Stocks; Car Makers, Miners, Biotechs Sacked
at Investor's Business Daily - Tue Sep 22, 9:46AM CDT
Sellers owned the early show on Tuesday, with stocks opening to losses that were broad and deep. The Nasdaq quickly slumped 1.5%. The Dow Jones industrial average and the S&P 500 each dropped 1.3%. Volume was tightly mixed, up 8% on the NYSE and 3%...
SPLS: 12.58 (+0.09), VRX: 118.61 (-28.13), F: 15.41 (+0.03), UTX: 97.97 (+2.35), FCAU: 15.20 (-0.74), NTAP: 33.40 (-0.32), TTM: 28.78 (-0.12), KMX: 57.30 (+0.35), LCI: 41.15 (-2.50), AZO: 745.29 (-0.65), GM: 35.42 (+1.94), MCD: 102.54 (-1.30)
McKesson to Buy UDG Healthcare's Pharmaceutical Business
Zacks Equity Research - Zacks Investment Research - Mon Sep 21, 2:55PM CDT
McKesson Corporation (MCK) signed an agreement to purchase UDG Healthcare's pharmaceutical distribution division for 408 million euro in cash.
LCI: 41.15 (-2.50), MCK: 186.62 (-2.71), ADHD: 6.49 (-0.20)
Major Indexes Still Mixed; Red Hat Up Ahead Of Earnings
at Investor's Business Daily - Mon Sep 21, 1:52PM CDT
Stocks have come off their session lows, but were still mixed late Monday. The Nasdaq cut a 0.6% deficit to 0.2%. But the tech-laden index was up as much as 1.1% intraday. The S&P 500 edged up 0.2% while the Dow Jones industrial average outperformed...
AGN: 259.00 (-4.42), LCI: 41.15 (-2.50), VRX: 118.61 (-28.13), CYBR: 46.41 (-3.11), RHT: 76.81 (-1.45), ILMN: 140.17 (-4.93), REGN: 518.53 (+3.86)
3 Reasons Why Lannett Company (LCI) is a Great Value Stock
Zacks Equity Research - Zacks Investment Research - Fri Sep 18, 7:52AM CDT
Lannett Company is a solid value stock that is very well-positioned for gains in the near term
LCI: 41.15 (-2.50)
'Mad Money' Lightning Round: Buy, Buy, Buy Amazing Starbucks
at The Street - Thu Sep 17, 5:00AM CDT
Cramer prefers Wells Fargo over HSBC Holdings and Kroger over Whole Foods Markets.
WFM: 32.98 (-0.24), SBUX: 60.53 (-0.35), LCI: 41.15 (-2.50), KR: 38.08 (+0.36), HSBC: 38.93 (-0.94), WFC: 53.12 (+0.04)
